Sodium dichloroacetate
- Generic Name
- Sodium dichloroacetate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C2HCl2NaO2
- CAS Number
- 2156-56-1
- Unique Ingredient Identifier
- 42932X67B5
- Associated Conditions
- -
- Associated Therapies
- -
Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT01083524
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇬🇧Imperial College, London, United Kingdom
A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Cardiometabolics
- Target Recruit Count
- 80
- Registration Number
- NCT00500929
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 45
- Registration Number
- NCT00004490
Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia
Phase 2
Completed
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 75
- Registration Number
- NCT00004493
- Locations
- 🇺🇸
University of California San Diego School of Medicine, La Jolla, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath